Loading...
This record has been deleted. Since it is linked to a published record, it is available here for reference purposes only.
Click here to view the deleted recordThis document has been updated. This is not the latest published version. Click here to view the latest version of the record.
Internationally Recognized Certificates of Compliance
(IRCC)
last updated: 21 Sep 2019
ABSCH-IRCC-IN-247828-1
Competent National Authority:National Biodiversity Authority ()5th Floor, TICEL Biopark, CSIR Road, TaramaniChennai, Tamilnadu
600 113, IndiaPhone: +91 44 2254 2777,Fax: +91 44 2254 1200,Website: http://www.nbaindia.org,
India/NBA/Appl/9/133-A21
Application in Form-III for seeking approval for the invention on "Non toxic herbal formulation extracted from plants useful for anti cancer" for obtaining IP Rights in India.
Indian Patent Application Number: 1321/DEL/2007
18 Jan 2019
Yes
Competent National Authority:National Biodiversity Authority ()5th Floor, TICEL Biopark, CSIR Road, TaramaniChennai, Tamilnadu
600 113, IndiaPhone: +91 44 2254 2777,Fax: +91 44 2254 1200,Website: http://www.nbaindia.org,
Confidential information
-
Organization:
Council of Scientific and Industrial Research
(CSIR)
|
ABSCH-CON-IN-239442-1
This linked record has been deleted.
Organization:Council of Scientific and Industrial Research (CSIR)Academic or research institute3rd Floor, NISCAIR Building, 14, Satsang Vihar Marg, Special Institutional Area,New Delhi, New Delhi
110067, IndiaPhone: +91 1126962560, +91 26965613,Fax: +91 26968819,Email: head.ipu@niscair.res.in,Website:
Confidential information
Yes
1. The user shall notify NBA within six months from the date of grant of IPR.
2. The user shall inform NBA about any commercialization made on the IP Rights granted.
3. The user shall submit half yearly report to NBA as per the terms and conditions agreed upon.
For obtaining IP Rights on the Invention "Non toxic herbal formulation extracted from plants useful for anti cancer" in India
Biological Resources:
Withania somnifera
Withania somnifera
Confidential information
- Commercial
1. If the user assigns/licenses the process/product/innovation to a third party for commercialization, the user shall pay 2.0% of the net revenue ( in any form like royalty or license fee / assignee fee) excluding government taxes and levies received annually from the assignee/licensee.
2. In case the user assigns or transfers the IPR in whole or in part to any person, whether voluntarily or involuntarily, the user undertakes to attach this agreement as an appendix to the assignment instrument, which shall be binding upon such person
| Unique identifier | Status | Date |
|---|---|---|
| ABSCH-IRCC-IN-247828-1 |
REVOKED
OLD VERSION
PUBLISHED
DELETED
|
Sujata Arora (sujata@nic.in)
21 Sep 2019 13:28 on 21 Sep 2019 13:28
|
